Lutikizumab improves clinical responses and pain outcomes in patients with hidradenitis suppurativa after anti-TNF failure in a phase 2 study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/lutikizumab-offers-relief-moderate-severe-hidradenitis-2026a10008dn?src=rss
Author :
Publish date : 2026-03-19 07:45:00
Copyright for syndicated content belongs to the linked Source.
